Jonathan Krinsky, chief market technician at BTIG, joins CNBC's 'The Exchange to discuss his outlook on stocks for 2025, what ...
Carvana (CVNA) shares remain under pressure on the heels of a scathing short-seller report despite Wall Street analysts ...
BTIG analyst Marvin Fong maintained a Buy rating on Carvana Co (CVNA – Research Report) yesterday and set a price target of $295.00.Don't Miss ...
Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $1.9 which represents no change from the prior close of of $1.9. The stock opened at $1.9 and touched a low of $1.87 during ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 13.40% ...
BTIG notes that Casago has agreed to acquire Neutral-rated Vacasa (VCSA) for $5.02/share in cash with the deal expected to close Q1-Q2 2025.
BTIG raised the firm’s price target on Insulet (PODD) to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical Technology ...
BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $101 from $97 and keeps a Buy rating ...
U.S. stocks got off to a rocky start to 2025 on Thursday as the S&P 500 and Nasdaq Composite declined for a fifth straight ...
Analyst initiates coverage on cloud-based auto services provider SunCar Technology (SDA) with Buy rating, projecting 25% annualized growth.
The report centers on Carvana’s practice of loan sales as well as the business relationship between CEO Ernie Garcia III and ...
According to a BTIG strategist, the rally in the index was rejected from the previous support trendline and even though there are still four days left for the Santa Claus rally to deliver gains, there ...